Pediatric ALL Clinical Trial
Official title:
Design and Evaluation of Care Environment and Technology at Pediatric Radiotherapy
The purpose of the study is to evaluate the effect of changes in the care environment in
pediatric radiotherapy. The definitions of the changes is a part of the study, and is
constructed in collaboration with the institute of design at Umeå University. The
implementation is however not part of the study, but done as part of Clinical routine.
The study consist of two parts, where the first 1.5 years are a Control phase where the
changes are designed and also function as a baseline period. The following 1.5 years are the
case period where the Changes that are accepted for Clinical implementation are implemented.
The impact of the changes are evaluated using surveys and interviews of both parents and
children
The purpose of the study is to evaluate the effect of changes in the care environment in
pediatric radiotherapy. The definitions of the changes is a part of the study, and is
constructed in collaboration with the institute of design at Umeå University. The
implementation is however not part of the study, but done as part of Clinical routine.
The study consist of two parts, where the first 1.5 years are a Control phase where the
changes are designed and also function as a baseline period. The following 1.5 years are the
case period where the Changes that are accepted for Clinical implementation are implemented.
The impact of the changes are evaluated using surveys and interviews of both parents and
children. Interviews of the personnel regarding their experiences of the study and the
changes is performed after the finalization of the case period.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05818644 -
Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children
|
||
Not yet recruiting |
NCT06018324 -
CloudCare in the Treatment of Type 1 Diabetes in Pediatrics
|
||
Not yet recruiting |
NCT04523623 -
Pain Control Differences Between Oxycodone and Ibuprofen in Children With Isolated Forearm Injuries
|
N/A | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT03385681 -
Pediatric Pain Management - an Intervention Study
|
N/A | |
Completed |
NCT00229671 -
Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics
|
N/A | |
Completed |
NCT04465370 -
Pediatric Cardiac Output Monitoring Observational Study
|
||
Recruiting |
NCT04100070 -
Intensive Versus Standard One Year Monitoring on Glycaemic Control After Initiating CSII in Children With DT1. DEEP Study
|
N/A | |
Not yet recruiting |
NCT06035757 -
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
|
Phase 4 | |
Completed |
NCT03369847 -
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
|
Phase 4 | |
Completed |
NCT05474170 -
Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest
|
N/A | |
Recruiting |
NCT05230004 -
Innovative Prosthetic Systems for Pediatric Limb Loss to Accommodate Growth
|
N/A | |
Completed |
NCT06376188 -
Improving Breaking Bad News in Pediatrics by Simulated Communication
|
N/A | |
Completed |
NCT05731401 -
Expressed Beliefs About the Cause of Pain in a Paediatric Population
|
||
Completed |
NCT05818215 -
Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
|
||
Completed |
NCT04589910 -
Measuring Thickness of the Normal Diaphragm in Children Via Ultrasound.
|
N/A | |
Recruiting |
NCT04252508 -
Impact of a Double-reading Animated Film (Child, Parents) in Preoperative on the Anxiety of Children Upon Arrival at the Operating Room
|
N/A | |
Completed |
NCT04655378 -
Validation of the IgA1 Detection Method With Gradient Glycosylation by Mass Spectrometry as a Potential Marker of Renal Involvement in Pediatric Rheumatoid Purpura
|
||
Completed |
NCT04610918 -
Comparing Body Composition Assessment Methods
|
||
Completed |
NCT03964259 -
Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia
|
Phase 1 |